- Home
- NETD vs PACB Comparison
NETD vs PACB Comparison
Compare NETD & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NETD
- PACB
- Stock Information
- Founded
- NETD 2023
- PACB 2000
- Country
- NETD United States
- PACB United States
- Employees
- NETD N/A
- PACB N/A
- Industry
- NETD
- PACB Biotechnology: Laboratory Analytical Instruments
- Sector
- NETD
- PACB Industrials
- Exchange
- NETD Nasdaq
- PACB Nasdaq
- Market Cap
- NETD 417.9M
- PACB 364.2M
- IPO Year
- NETD 2023
- PACB 2010
- Fundamental
- Price
- NETD $11.03
- PACB $1.15
- Analyst Decision
- NETD
- PACB Buy
- Analyst Count
- NETD 0
- PACB 10
- Target Price
- NETD N/A
- PACB $2.45
- AVG Volume (30 Days)
- NETD 199.6K
- PACB 7.0M
- Earning Date
- NETD 01-01-0001
- PACB 05-08-2025
- Dividend Yield
- NETD N/A
- PACB N/A
- EPS Growth
- NETD N/A
- PACB N/A
- EPS
- NETD 0.45
- PACB N/A
- Revenue
- NETD N/A
- PACB $152,357,000.00
- Revenue This Year
- NETD N/A
- PACB $6.13
- Revenue Next Year
- NETD N/A
- PACB $21.55
- P/E Ratio
- NETD $24.45
- PACB N/A
- Revenue Growth
- NETD N/A
- PACB N/A
- 52 Week Low
- NETD $10.50
- PACB $1.06
- 52 Week High
- NETD $11.10
- PACB $2.72
- Technical
- Relative Strength Index (RSI)
- NETD 63.81
- PACB 47.60
- Support Level
- NETD $10.97
- PACB $1.08
- Resistance Level
- NETD $11.03
- PACB $1.23
- Average True Range (ATR)
- NETD 0.03
- PACB 0.06
- MACD
- NETD 0.00
- PACB 0.01
- Stochastic Oscillator
- NETD 50.00
- PACB 52.94
About NETD Nabors Energy Transition Corp. II
Nabors Energy Transition Corp II is a blank check company.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.